Colistin resistance in Parisian inpatient faecal Escherichia coli as the result of two distinct evolutionary pathways

The authors showed that the occurrence at a high rate of colistin resistance in human faecal E. coli is the result of two distinct evolutionary pathways, i.e. the occurrence of chromosomal mutations in an endogenous E. coli population and the rare acquisition of exogenous mcr-1-bearing strains probably of animal origin. The involved selective pressures need to be identified in order to develop preventative strategies.

Article: Journal of Antimicrobial Chemotherapy

Smart Innovations  
Back


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed